Vivo Bio Tech Ltd. Press Release Jan 08 2026
Filed with BSE · · 1 page · English
The said subscription has been made pursuant to the approval accorded by the shareholders of Virinchi Limited at its Extra-Ordinary General Meeting held on Saturday, November 15, 2025 and pursuant to the in-principle approval given by BSE vide their letter LOD/PREF/KS/FIP/1456/2025-26 dated December 31, 2025; and by NSE vide their letter NSE/LIST/51564 dated December 31, 2025. The Convertible Equi
Earlier from Vivo Bio Tech
- Vivo Bio Tech Ltd. Press Release Jan 06 2026
- Announcement under Regulation 30 (LODR)-Allotment
- Vivo Bio Tech Ltd. Press Release Jan 05 2026
- Receipt Of Certificate Of GLP Compliance From National Good Laboratory Practice (GLP) Compliance Monitoring Authority (NGCMA), Department Of Science And Technology, Government Of India
- Vivo Bio Tech Ltd. Press Release Dec 27 2025
Later from Vivo Bio Tech
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
- Vivo Bio Tech Ltd. Press Release Jan 09 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Vivo Bio Tech Ltd. Press Release Jan 16 2026
- Board Meeting Intimation for Meeting To Be Held On Friday, February 13, 2026
Follow Vivo Bio Tech into a list and get an email when it puts out news.
Follow Vivo Bio Tech